Literature DB >> 1499014

Novel serotonergic mechanisms and clinical experience with nefazodone.

R Fontaine1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1499014     DOI： 10.1097/00002826-199201001-00054

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  4 in total

Review 1.  Clinical pharmacokinetics of nefazodone.

Authors:  D S Greene; R H Barbhaiya
Journal:  Clin Pharmacokinet       Date:  1997-10       Impact factor: 6.447

2.  Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment.

Authors:  R H Barbhaiya; U A Shukla; D S Greene
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

3.  Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function.

Authors:  R H Barbhaiya; M E Brady; U A Shukla; D S Greene
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

4.  Controlled comparison of nefazodone and amitriptyline in major depressive inpatients.

Authors:  M Ansseau; P Darimont; A Lecoq; A De Nayer; J L Evrard; P Krémer; J M Devoitille; M Dierick; C Mertens; F Mesotten
Journal:  Psychopharmacology (Berl)       Date:  1994-06       Impact factor: 4.530
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.